Yüklüyor......
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
CD19 Chimeric antigen receptor (CAR) T cell therapy has been shown to be effective for B cell leukemia and lymphoma. Many researchers are now trying to develop CAR T cells for various types of cancer. For multiple myeloma (MM), B-cell maturation antigen (BCMA) has been recently proved to be a promis...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966463/ https://ncbi.nlm.nih.gov/pubmed/31847470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11122024 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|